Global Endovascular Treatment Devices Market: Overview
Endovascular procedures have gained increased traction in clinical practice, especially in acute ischemic strokes and for a wide range of aneurysm repair. In particular, endovascular treatment devices are gaining significance in the treatment of patients with intracranial aneurysms. Constant strides made in endovascular procedures have made difficult untreatable aneurysms easy to manage with the advent of novel treatment devices in the global healthcare systems.
Despite the rising clinical efficacy of newly developed endovascular treatment devices, it is imperative to carefully weigh in the associated risks of accelerating their regulatory approvals in developed regions. This is a useful strategy in reducing the reported incidence of safety issues in the use of various endovascular treatment devices. Relentless focus on innovation in endovascular treatment of substantial numbers of cerebral aneurysms aims at improving clinical outcome of previously available devices across the globe.
The insights and assessments offered in the study on the global endovascular treatment devices help stakeholders and policy makers in various countries identify promising frontiers. The study tends to shine light on major product approvals and their role in emerging treatment avenues in key regions.
Global Endovascular Treatment Devices Market: Trends and Opportunities
The rising incidence of aortic aneurysms in various parts of the world is a key factor driving the demand for endovascular treatment devices. The rising adoption of minimally-invasive tests for the diagnosis is a key factor supporting the demand. The rising acceptance of endovascular procedures for treating acute ischemic strokes and aortic repair supported by a growing body of clinical research is propelling the growth of the endovascular treatment devices market. Over the past several years, endovascular aneurysm treatment options have risen in popularity, owing to their increased clinical outcomes. In recent years, the global endovascular treatment devices market has witnessed a slew of new devices with better safety profile and efficacy. The rising need for novel devices for endovascular treatment of intracranial aneurysms is a notable trend creating new, exciting avenues for market players.
Favorable reimbursement scenario for endovascular procedures is expected to catalyze the growth of the market. Focus of medical device manufacturers in developed and developing countries on design innovations is likely to drive innovations in the not-so-distant future. Rising number of clinical studies and in vitro experiments in thoracic endovascular aortic/aneurysm repair (TEVAR) are catalyzing the rapid expansion of the endovascular treatment devices market. The growing number of marketed and pipelined products on endovascular procedures is also fueling the market’s growth.
Global Endovascular Treatment Devices Market: Regional Outlook
The report takes a closer look at emerging dynamics of the endovascular treatment devices market in various regions and key trends that will create lucrative prospects over the assessment period of 2018–2026. The study also assesses the growth potential of developing regions, notably Asia Pacific, and takes a keen look at niche segments. Of the various key regions, developed regions occupy prominent role in the expansion of the endovascular treatment devices market. Of note, Europe and North America may occupy substantial shares in the global market in the next few years. Rapidly growing pipeline of products and fast-paced regulatory approvals will make these regions increasingly revenue generating in the coming few years.
Global Endovascular Treatment Devices Market: Competitive Landscape
The study takes a closer look at the key elements of the competitive dynamics and product pipelines of key companies. The report also highlighted the prospects of recently marketed products and the impact they have on the strategic contours of the endovascular treatment devices market. Key players operating in the market may include Terumo Corporation, Nellix, Inc., Lombard Medical Technologies, Lifetech Scientific, InspireMD, Endospan, Cardinal Health, and Boston Scientific.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.